1295 related articles for article (PubMed ID: 10664539)
1. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
2. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
[TBL] [Abstract][Full Text] [Related]
4. Biorelevant media resistant co-culture model mimicking permeability of human intestine.
Antoine D; Pellequer Y; Tempesta C; Lorscheidt S; Kettel B; Tamaddon L; Jannin V; Demarne F; Lamprecht A; Béduneau A
Int J Pharm; 2015 Mar; 481(1-2):27-36. PubMed ID: 25601199
[TBL] [Abstract][Full Text] [Related]
5. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer.
Pontier C; Pachot J; Botham R; Lenfant B; Arnaud P
J Pharm Sci; 2001 Oct; 90(10):1608-19. PubMed ID: 11745719
[TBL] [Abstract][Full Text] [Related]
6. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design.
Chen XM; Elisia I; Kitts DD
J Pharmacol Toxicol Methods; 2010; 61(3):334-42. PubMed ID: 20159047
[TBL] [Abstract][Full Text] [Related]
7. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
8. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans.
Walter E; Janich S; Roessler BJ; Hilfinger JM; Amidon GL
J Pharm Sci; 1996 Oct; 85(10):1070-6. PubMed ID: 8897273
[TBL] [Abstract][Full Text] [Related]
9. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies.
Araújo F; Sarmento B
Int J Pharm; 2013 Dec; 458(1):128-34. PubMed ID: 24120728
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monoculture.
Lozoya-Agullo I; Araújo F; González-Álvarez I; Merino-Sanjuán M; González-Álvarez M; Bermejo M; Sarmento B
Mol Pharm; 2017 Apr; 14(4):1264-1270. PubMed ID: 28263609
[TBL] [Abstract][Full Text] [Related]
12. Intestinal transport of methylmercury and inorganic mercury in various models of Caco-2 and HT29-MTX cells.
Vázquez M; Calatayud M; Vélez D; Devesa V
Toxicology; 2013 Sep; 311(3):147-53. PubMed ID: 23793072
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.
Antunes F; Andrade F; Araújo F; Ferreira D; Sarmento B
Eur J Pharm Biopharm; 2013 Apr; 83(3):427-35. PubMed ID: 23159710
[TBL] [Abstract][Full Text] [Related]
14. Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation.
Li N; Wang D; Sui Z; Qi X; Ji L; Wang X; Yang L
Tissue Eng Part C Methods; 2013 Sep; 19(9):708-19. PubMed ID: 23350801
[TBL] [Abstract][Full Text] [Related]
15. Paracellular calcium transport across Caco-2 and HT29 cell monolayers.
Blais A; Aymard P; Lacour B
Pflugers Arch; 1997 Jul; 434(3):300-5. PubMed ID: 9178630
[TBL] [Abstract][Full Text] [Related]
16. In-vitro investigation regarding the effects of Gelucire
Dubray O; Jannin V; Demarne F; Pellequer Y; Lamprecht A; Béduneau A
Int J Pharm; 2016 Dec; 515(1-2):293-299. PubMed ID: 27720954
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
[TBL] [Abstract][Full Text] [Related]
18. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
[TBL] [Abstract][Full Text] [Related]
20. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Yu L; Zeng S
J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
